Latest Hydrocodone Stories
WAYNE, Pa., Oct.
WAISMANN METHOD® Medical Director Recognizes Patient Trend and Suggests Strategies to Address Potential Dependency Issues ORANGE, Calif., Oct.
Pain Insights, Inc.
New white paper released as hydrocodone is reclassified as a Schedule II drug ITASCA, Ill., Oct.
KemPharm's Intellectual Property Estate Now Includes Composition of Matter Patents for Two Ligand Activated Technology (LAT) Opioid Prodrugs - KP511 and KP201 CORALVILLE, Iowa, Sept.
KemPharm Joins CLADD in Support of Legislation from Health Canada to Encourage More Responsible Development and Administration of Prescription Opioids CORALVILLE, Iowa, Sept.
Studies to Investigate Ability of KP201 to Deter Abuse and Reduce Opioid-Induced Constipation CORALVILLE, Iowa, Sept.
STAMFORD, Conn., Sept.
DEA’s announcement comes after a recommendation last year concerning the potent combination drug products. Port Washington, New York (PRWEB) August 29, 2014
Controversial Hydrocodone-Based Painkiller Zohydro contains strong potential for addiction and as a substitute for OxyContin and heroin abuse.
- A hairdresser.